Skip to main content
Premium Trial:

Request an Annual Quote

Microchip Biotechnologies Licenses Sample Loading System Tech from UC Berkeley

NEW YORK (GenomeWeb News) — Microchip Biotechnologies said today that it has licensed a patent and its related applications from the University of California, Berkeley.
According to MBI, the privately held firm has obtained an exclusive license for US Patent No. 6,623,613, "Microfabricated Liquid Sample Loading System" and related patent applications developed by UC Berkeley Professor Richard Mathies and his team.
Stevan Jovanovich, president and CEO of MBI, called the IP “foundational to MBI's ongoing development of a … nanofluidics platform for the construction of integrated devices."
Microchip Biotechnologies develops nanofluidic sample preparation and analytical instrumentation for the genomics and biodefense markets.
Last week, the company announced that it had raised $4.5 million in a Series A funding round.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.